Skip to main content

Igal Luchamivitz

Analyst

Citigroup

Equibles does not estimate personal net worth.

About Igal Luchamivitz

Igal Luchamivitz is recorded as Analyst at Citigroup. Igal Luchamivitz has spoken on 1 earnings call across 1 company, most recently for Summit Therapeutics Inc. on July 23, 2026. The companies whose calls Igal Luchamivitz spoke on are classified in the Healthcare sector.

Igal Luchamivitz on recent calls

“So very interesting, recent updated overall survival cut from the second line EGFR study.”
Analyst — Citigroup, Summit Therapeutics Q2 2026 Earnings Call ·

Affiliation history

  • Citigroup

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity